KU Hematology & Medical Oncology Review 2019
KU ASCO 2019 Targeted Therapy Drugs for AML - CPX-351, FLT3, IDH Inhibitors, BCL-2, & Hedgehog Pathway Inhibitor
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Tara Lin
By
KU Hematology & Medical Oncology Review 2019
FEATURING
Tara Lin
Comments 0
Login to view comments.
Click here to Login
